Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-19-000618

Options or other derivatives

  • SVP, GC and Corporate Affairs acquired 120,968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mitchell Shawnte SVP, GC and Corporate Affairs 2019-11-01 Grant or award · Stock Option (right to buy) +120,968 120,968 D
Loading xslF345X03/mitchell.xml…